Congenital adrenal hyperplasia

Principles of Molecular Medicine

Volumn , Issue , 2006, Pages 365-376

  Wilson, Robert C ^a   New, Maria I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

17 hydroxylase 17; 20 lyase deficiency; 21 hydroxylase deficiency (21 OHD); 3 hydroxysteroid dehydrogenase deficiency; adrenal hyperplasia; Adrenal steroidogenesis; congenital adrenal; hyperplasia (CAH); lipoid congenital; salt wasting

Indexed keywords

EID: 81055129326     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-963-9_37     Document Type: Chapter

References (24)

1. Bongiovanni AM. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase deficiency. In: New MI, Levine LS, eds. Adrenal Disease in Childhood, Pediatric and Adolescent Endocrinology, Volume 13. Basel: S Karger, 1984; pp. 72-82.
2. Forest MG, David M, Morel Y. Prenatal diagnosis and treatment of 21- hydroxylase deficiency. J Steroid Biochem Mol Biol 1993;45:75-82.
3. Kater CE, Biglieri EG. Disorders of steroid 17α-hydroxylase deficiency. Endocrinol Metab Clinic North Am 1994;23:341-357.
4. Cooper DN, Ball EV, Stenson PD. The human gene mutation database. University of Wales College of Medicine. http://www.hgmd.org/. June 23, 2004.
5. http://archive.uwcm.ac.uk/uwcm/mg/hgmd0.html2004
6. http://www.hgmd.org/2004
7. Lin D, Sugawara T, Strauss JF III, et al. The molecular basis of congenital lipoid adrenal hyperplasia. Pediatr Res 1995;37:545/93A.
8. Mornet E, Crete P, Kuttenn F, et al. Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. Am J Hum Genet 1991;48:79-88.
9. New MI, Crawford C. Molecular genetics of steroid 21-hydroxylase deficiency. In:Wachtel S, ed. Molecular Genetics of Sex Determination. New York: Academic Press, 1994; pp. 399-438.
10. New MI, White PC. Genetic disorders of steroid metabolism. In: Thakker R, ed. Genetic and Molecular Biological Aspects of Endocrine Disease. London: Bailliere Tindall, 1995; pp. 525-554.
11. New MI,Wilson RC. Inaugural article: Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci USA 1999;96:12,790-12,797.
12. New MI, Crawford C,Wilson RC. Genetic disorders of the adrenal gland. In: Rimoin DL, Connor JM, Pyeritz RE, eds. Principles and Practice of Medical Genetics, 3rd ed. New York: Churchill Livingstone, 1996; pp. 1441-1476.
13. New MI, Carlson A, Obeid J, et al. Update on prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001;86:5651-5657.
14. Pang S, Clark A. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993;2:105-139.
15. Sparkes RS, Kilsak I, Miller WL. Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25. DNA Cell Biol 1991;10:359-365.
16. Speiser PW, Dupont J, Zhu D, et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992;90:584-595.
17. Stocco DM, Clark BJ. Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem Pharmacol 1996;51: 197-295.
18. Wajnrajch JP, New MI. Defects of adrenal steroidogenesis. In: DeGroot LJ, Jameson JL, eds. Endocrinology, 4th ed. Philadelphia: Saunders, 2001; pp. 1721-1739.
19. White PC, Curnow KM, Pascoe L. Disorders of steroid 11beta-hydroxylase isozymes. Endocr Rev 1994;15:421-438.
20. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-291.
21. White PC, New MI, Dupont J. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 1986;83:5111-5115.
22. Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995;80:2322-2329.
23. Yanase T, Simpson ER, Waterman MR. 17α-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 1991;12:91-108.
24. Zerah M, Schram P, New MI. The diagnosis and treatment of nonclassical 3beta-HSD deficiency. Endocrinologist 1991;1:75-81.